LC-UV-electrospray-MS-MS mass spectrometry analysis of plant constituents inhibiting xanthine oxidase

被引:18
作者
Gariboldi, E
Mascetti, D
Galli, G
Caballion, P
Bosisio, E
机构
[1] Univ Milan, Inst Pharmacol Sci, Fac Pharm, I-20122 Milan, Italy
[2] ORSTOM, Noumea, New Caledonia
关键词
xanthine oxidase inhibitors; flavonoids; proanthocyanidins; electrospray mass spectrometry; Amyena scandens;
D O I
10.1023/A:1011941002546
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose, A previous screening showed that Amyena scandens Danser (Loranthaceae) efficiently inhibited XOD. The aim of this study was to identify the compounds with anti-XOD properties. For this purpose, Electrospray Tandem Mass Spectrometry (ESI-MS-MS) coupled with UV and Diode Array LC techniques were employed. Methods, Leaves were delipidized with petroleum ether and extracted with acetone:water 70:30, v:v. The extract was fractionated into the ethyl acetate and water soluble phases. Chemical investigation was performed following the bioactivity guided fractionation. Two fractions with anti-XOD activity were isolated by silica gel column chromatography of the ethyl acetate phase and analyzed by LC-UV-ESI-MS-MS. Results, The compounds identified with authentic standards were: catechin, epicatechin, epicatechin-3-gallate, quercetin-3-O-glucoside, quercetin-3-O-rhamnoside, and isorhamnetin-3-O-glucoside. Other constituents, only partially characterized, were a procyanidin dimer, a procyanidin trimer, three dimers epi/catechine-epi/catechine gallate and isorhamnetin-O-deoxyhexose. The anti-XOD activity was mainly due to galloyl-containing oligomeric proanthocyanidins. Conclusions, The coupling of UV Diode Array-HPLC with ESI-MS-MS represents a versatile tool for the rapid characterization of compounds in complex mixtures, avoiding time-consuming previous isolation.
引用
收藏
页码:936 / 943
页数:8
相关论文
共 23 条
  • [1] [Anonymous], J CHEM SOC P
  • [2] BAKTHTIAR A, 1994, PHYTOCHEM ANALYSIS, V5, P86
  • [3] INVOLVEMENT OF REACTIVE OXYGEN SPECIES IN KIDNEY DAMAGE
    BAUD, L
    ARDAILLOU, R
    [J]. BRITISH MEDICAL BULLETIN, 1993, 49 (03) : 621 - 629
  • [4] BOSISIO E, UNPUB INT J PHARMACO
  • [5] COSTANTINO L, 1995, PHARMAZIE, V50, P573
  • [6] DEPOULET AC, 1994, OXIDATIVE PROCESSES, P73
  • [7] FACINO RM, 1994, ARZNEIMITTEL-FORSCH, V44-1, P592
  • [8] FERRARI R, 1994, ADV EXP MED BIOL, V366, P99
  • [9] GONZALEZ AG, 1995, J ETHNOPHARMACOL, V462, P5
  • [10] HATANO T, 1990, CHEM PHARM BULL, V38, P1224